Applied Therapeutics, Inc. (NASDAQ: APLT) reported Q3 EPS of ($0.47), $0.23 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Applied Therapeutics, Inc. (APLT) click here.